TIGR - CEI CEMI and CBIO among pre market gainers
IVERIC bio (NASDAQ:ISEE) +65% Apellis' mixed eye-drug data turns out to be 'positive' for Iveric Bio Vince Holding (NYSE:VNCE) +22% on Q2 earnings. Affirm Holdings (NASDAQ:AFRM) +21% on Q4 earnings. Endo International (NASDAQ:ENDP) +18% settles New York state opioid lawsuits for total payment $50M Katapult Holdings (NASDAQ:KPLT) +13%. Catalyst Biosciences (NASDAQ:CBIO) +13% announces oral and poster presentations at the International Conference on complement therapeutics Arbutus Biopharma (NASDAQ:ABUS) +12% on apparent patent fight win with Moderna So-Young International (NASDAQ:SY) +10% on Q2 earnings. Greenlane Holdings (NASDAQ:GNLN) +10%. Dave & Buster's Entertainment (NASDAQ:PLAY) +9% on Q2 earnings. Camber Energy (NYSE:CEI) +8%. Chembio Diagnostics (NASDAQ:CEMI) +6%. UP Fintech Holding (NASDAQ:TIGR) +6% on Q2 earnings. Enveric Biosciences (NASDAQ:ENVB) +5%.
For further details see:
CEI, CEMI and CBIO among pre market gainers